Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.
about
Physical Activity, Air Pollution and the BrainCCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cellsSystemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injuryA Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future ProspectsHerpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's DiseaseInsights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesTraumatic brain injury, neuroinflammation, and post-traumatic headachesRole of prostaglandins in neuroinflammatory and neurodegenerative diseasesUncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/β-catenin signaling cascade as the common final pathway for neuroprotection and self-repairNeuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative diseaseInhibition of microglia activation as a phenotypic assay in early drug discoveryDietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseasesPotential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs diseaseAAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's diseaseEmerging Roles for the Immune System in Traumatic Brain InjuryMorgellons disease: a filamentous borrelial dermatitisProtective Microglia and Their Regulation in Parkinson's DiseaseImaging neuroinflammation in multiple sclerosis using TSPO-PETGlial modulators as potential treatments of psychostimulant abuseParoxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signalingThe protective effect of melatonin on neural stem cell against LPS-induced inflammationInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseEffects of cordycepin on the microglia-overactivation-induced impairments of growth and development of hippocampal cultured neuronsTGF-beta1 blockade of microglial chemotaxis toward Abeta aggregates involves SMAD signaling and down-regulation of CCL5Acetaminophen inhibits neuronal inflammation and protects neurons from oxidative stressInhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicityA Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotectionAmeliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain InjuryAnti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice.Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis.Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.Gene expression patterns associated with neurological disease in human HIV infectionQingkailing Suppresses the Activation of BV2 Microglial Cells by Inhibiting Hypoxia/Reoxygenation-Induced Inflammatory Responses.Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative DiseasesOxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.DJ-1 deficient mice demonstrate similar vulnerability to pathogenic Ala53Thr human alpha-syn toxicity.Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor/NADPH oxidase-mediated chemotaxis in miceAdenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's diseaseCerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
P2860
Q22337355-8A565EBD-33A8-435D-AE79-FDE0EF0F78CEQ24633405-F4E615C8-5DD6-4329-8354-D3C8702E3AADQ24642504-E4A584B2-C734-4B30-A531-3DB33369BFF2Q26746033-2FD3B28E-41B5-416F-8A85-C28894B1CF99Q26781578-8A6A7E3E-836C-489E-993A-9B71AB468744Q26795984-3A3611E2-E8FC-49EE-911F-6A443A5C10E8Q26830912-7611457D-5AB4-4A44-BB93-3F0A08C66021Q26863534-161C4BF7-AD4C-4111-931C-A7323F30EC00Q26865502-B9B4EC8A-FA57-4ED3-BD66-AE2E0D073A39Q26995351-31F13D5F-AC47-467D-87D0-43883EEC3751Q26996061-FF9CB0F5-5E3C-4787-BCF6-3B8BFA6E1B50Q27002456-32DDFE61-9367-4674-B25D-BD2988E83B04Q27012822-0937B9BF-2FB2-4FFD-A45A-218A685EF9F8Q27334472-38A195CB-AC9B-42E5-AA79-0A05DA9E3394Q28071271-96308D18-17F9-4991-882C-A4337F14EA11Q28072515-2608BFC5-8BA6-4B15-9A90-43B173C0B0D5Q28079731-580265C5-B0B5-45D9-A886-AB0DE1468398Q28084625-222379BE-0F83-4E1A-B39C-29AFBB9C3562Q28307030-F440B14A-9D53-4FFC-954D-0206DF53FFCEQ28384484-92EFA4B2-C243-4A7A-B600-E80A0C022870Q28388035-D203D6F2-329F-4F4B-A5B1-0757897BD7A0Q28391762-DD2C655D-B2AA-4BCB-B047-FDFD3100C6E2Q28546945-4C1B9989-82D4-4270-BE28-C9C349685D5BQ28568787-958EEDBE-AC28-46EB-BB85-F101D3500EEAQ28576204-8D66D12B-4288-4EA6-9186-1671FAA36DFAQ28577454-FE16F725-7280-4FA3-B25F-0C7E98A5C380Q28589470-42C9A160-54EE-4F72-9BB6-BA3E518764FFQ30387426-7D4AB6C2-D854-46E7-AE05-DFCBA1BE266DQ30536425-7211ADEA-1EF3-4BD8-8FCB-328B060CECCFQ30583469-876DE365-64EC-4FAD-9A04-DE285D5AAA20Q33112256-82A0D714-A1D7-43FC-8A64-93FD670B4D15Q33605737-B2FCB2A3-71FD-47AF-AF9F-0874DE8F0910Q33608619-788E644C-A339-44B2-8658-3231F01364FDQ33679220-FE247388-25C4-4F4A-80C1-4FE53B3611C3Q33714587-85FD28E5-9871-499F-A8E1-783971904E50Q33755817-09D632E2-A23D-4CAC-AED6-0253D77785D4Q33771694-3B16CBCC-D54D-49BA-90B2-8FDF08CFD07AQ33778623-231B29A6-C31F-4EBD-9F2B-090509FFD5BDQ33811654-CF24314C-7B53-4395-B4A9-A9A6243FE602Q33863368-4A0903E1-111F-4E13-9E8B-050D9FDDB9DC
P2860
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Why neurodegenerative diseases ...... on drives disease progression.
@ast
Why neurodegenerative diseases ...... on drives disease progression.
@en
type
label
Why neurodegenerative diseases ...... on drives disease progression.
@ast
Why neurodegenerative diseases ...... on drives disease progression.
@en
prefLabel
Why neurodegenerative diseases ...... on drives disease progression.
@ast
Why neurodegenerative diseases ...... on drives disease progression.
@en
P2860
P356
P1433
P1476
Why neurodegenerative diseases ...... ion drives disease progression
@en
P2093
Hui-Ming Gao
P2860
P304
P356
10.1016/J.IT.2008.05.002
P577
2008-07-01T00:00:00Z